Your browser doesn't support javascript.
loading
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy.
Crosby, Brendan J; Newton, Robert U; Galvão, Daniel A; Taaffe, Dennis R; Lopez, Pedro; Meniawy, Tarek M; Khattak, Muhammad A; Lam, Wei-Sen; Gray, Elin S; Singh, Favil.
Afiliação
  • Crosby BJ; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Newton RU; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Galvão DA; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Taaffe DR; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Lopez P; School of Human Movement and Nutrition Sciences, University of Queensland, Saint Lucia, Queensland, Australia.
  • Meniawy TM; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Khattak MA; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Lam WS; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Gray ES; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Singh F; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
Cancer Med ; 12(13): 14694-14706, 2023 07.
Article em En | MEDLINE | ID: mdl-37184115

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Melanoma Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Melanoma Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália